410 related articles for article (PubMed ID: 9307275)
41. [An approach to early genetic alterations in precancerous cells].
Sato N; Nishida M; Noguchi M
Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
[TBL] [Abstract][Full Text] [Related]
42. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J
Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098
[TBL] [Abstract][Full Text] [Related]
43. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
44. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
Wappenschmidt B; Wardelmann E; Gehrig A; Schöndorf T; Maass N; Bonatz G; Gassel AM; Pietsch T; Mallmann P; Weber BH; Schmutzler RK
Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
[TBL] [Abstract][Full Text] [Related]
45. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
[TBL] [Abstract][Full Text] [Related]
46. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
47. Somatic mutation of PTEN in vulvar cancer.
Holway AH; Rieger-Christ KM; Miner WR; Cain JW; Dugan JM; Pezza JA; Silverman ML; Shapter A; McLellan R; Summerhayes IC
Clin Cancer Res; 2000 Aug; 6(8):3228-35. PubMed ID: 10955808
[TBL] [Abstract][Full Text] [Related]
48. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
[TBL] [Abstract][Full Text] [Related]
49. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
[TBL] [Abstract][Full Text] [Related]
50. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
[TBL] [Abstract][Full Text] [Related]
51. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
Poetsch M; Lorenz G; Kleist B
Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
[TBL] [Abstract][Full Text] [Related]
52. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
53. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.
Shao X; Tandon R; Samara G; Kanki H; Yano H; Close LG; Parsons R; Sato T
Int J Cancer; 1998 Aug; 77(5):684-8. PubMed ID: 9688299
[TBL] [Abstract][Full Text] [Related]
54. Molecular characterization of uterine clear cell carcinoma.
An HJ; Logani S; Isacson C; Ellenson LH
Mod Pathol; 2004 May; 17(5):530-7. PubMed ID: 14976538
[TBL] [Abstract][Full Text] [Related]
55. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung.
Petersen S; Rudolf J; Bockmühl U; Gellert K; Wolf G; Dietel M; Petersen I
Oncogene; 1998 Jul; 17(4):449-54. PubMed ID: 9696038
[TBL] [Abstract][Full Text] [Related]
56. Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma.
Salvesen HB; Stefansson I; Kalvenes MB; Das S; Akslen LA
Cancer; 2002 Apr; 94(8):2185-91. PubMed ID: 12001116
[TBL] [Abstract][Full Text] [Related]
57. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
[TBL] [Abstract][Full Text] [Related]
58. PTEN mutations and evolving concepts in endometrial neoplasia.
Latta E; Chapman WB
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):59-65. PubMed ID: 11801878
[TBL] [Abstract][Full Text] [Related]
59. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.
Wang H; Douglas W; Lia M; Edelmann W; Kucherlapati R; Podsypanina K; Parsons R; Ellenson LH
Am J Pathol; 2002 Apr; 160(4):1481-6. PubMed ID: 11943731
[TBL] [Abstract][Full Text] [Related]
60. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]